SCHEMBL29979341

SCHEMBL29979341

O=C(O)c1ccccc1-c1ccc(OC(F)F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
TEAD4 Q15561 1/20 0.58
GRM2 Q14416 1/20 0.50
TAS2R14 Q9NYV8 1/20 0.49
PPARG P37231 7/20 0.49
PPARA Q07869 7/20 0.49
EIF4E P06730 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
HNF4A P41235 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
DRD1 P21728 1/20 0.44
LTB4R2 Q9NPC1 1/20 0.43
TSHR P16473 1/20 0.43
BCAT2 O15382 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23354195 1.00 MEN1 (0.58) MEN1KMT2AALDH1A1MAPTTEAD4
SCHEMBL2597797 0.84 ALDH1A1 (0.57) KMT2AALDH1A1PPARGPPARASMN1; SMN2
SCHEMBL28036248 0.84 SMN1; SMN2 (0.55) MEN1KMT2AALDH1A1MAPTTEAD4
SCHEMBL31676836 0.83 SLC6A3 (0.66) MEN1KMT2AALDH1A1MAPTTEAD4
SCHEMBL23354413 0.83 SLC6A3 (0.66) MEN1KMT2AALDH1A1MAPTTEAD4
SCHEMBL18759613 0.80 HNF4A (0.63) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL30292805 0.80 HNF4A (0.63) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL11402358 0.80 GSTP1 (0.56) MEN1KMT2AALDH1A1HNF4ASMN1; SMN2
SCHEMBL4148464 0.79 PPARG (0.45) PPARGPPARAHNF4AFNTAFNTB
SCHEMBL11554621 0.78 HNF4A (0.61) MEN1KMT2AALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists BAYER AKTIENGESELLSCHAFT (DE) 2025-08-26 US disclosed
EP-4058448-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2022-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists ADAMTS7, MMP7, ADAM17 MEN1 2481/4885KMT2A 3535/4885ALDH1A1 3828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.